NNNN (Anbio Biotechnology Class A Ordinary Shares) Stock Analysis - AI Report

Anbio Biotechnology Class A Ordinary Shares (NNNN) is a publicly traded Healthcare sector company. As of May 21, 2026, NNNN trades at $31.00 with a market cap of $1.24B and a P/E ratio of 0.00. NNNN moved +2.57% today. Year to date, NNNN is -6.90%; over the trailing twelve months it is +298.00%. Its 52-week range spans $5.18 to $55.65. Rallies surfaces NNNN's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

What is the AI research view on NNNN?

Rallies AI research for NNNN combines live market data, fundamentals, news, analyst context, hedge fund holdings, politician trades, insider activity, and risk factors into a ticker-specific research workflow.

NNNN Key Metrics

Key financial metrics for NNNN
MetricValue
Price$31.00
Market Cap$1.24B
P/E Ratio0.00
EPS$0.00
Dividend Yield0.00%
52-Week High$55.65
52-Week Low$5.18
Volume110
Avg Volume0
Revenue (TTM)$0
Net Income$0
Gross Margin0.00%

Latest NNNN News

NNNN Analyst Consensus

NNNN analyst coverage data. Average price target: $0.00.

Common questions about NNNN

What is the AI research view on NNNN?
Rallies AI research for NNNN combines live market data, fundamentals, news, analyst context, hedge fund holdings, politician trades, insider activity, and risk factors into a ticker-specific research workflow.
What data powers the Rallies AI report for NNNN?
Rallies AI research for NNNN combines live market data, financials, news, analyst context, hedge fund ownership, politician disclosures, insider activity, and risk factors.
Is NNNN research on Rallies investment advice?
No. Rallies provides research, data, and educational context for NNNN. It does not provide personalized investment advice.
NNNN

NNNN